Clinical Trials Directory

Trials / Completed

CompletedNCT02468401

Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions

The Efficacy of a New Protocol for Preventing Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Meir Medical Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

There is a pressing need to find effective strategies for the prevention of contrast induced nephropathy in patients with advanced renal dysfunction. The current study was designed to assess the efficacy of a new protocol for preventing contrast induced nephropathy in patients with advanced renal dysfunction undergoing coronary interventions

Conditions

Interventions

TypeNameDescription
PROCEDUREPercutaneous coronary interventionPatients planned for coronary angiography or percutaneous coronary intervention will be managed using a protocol that allows us to use minimal volumes of contrast dye

Timeline

Start date
2015-09-01
Primary completion
2016-08-01
Completion
2016-08-01
First posted
2015-06-10
Last updated
2016-11-22

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02468401. Inclusion in this directory is not an endorsement.

Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions (NCT02468401) · Clinical Trials Directory